There are lots of "red flags" and conflicts presented in the 10Q that would not be present or certainly would be mitigated by an independent board. Do I think this stuff is in conflict with the clinical trials? Not sure. But, the re-negotiating of your own personal debt obligations, interest in other related companies, sweetening future stock warrants, accounting and "going concern" issues as noted by the company auditors, are all red flags.

If you are able to negotiate clinical trials at the best cancer research hospitals in the world and "sign" confidentiality agreements with multi-billion dollar pharma's, you certainly have the ability to identify a more than qualified BOD, don't you think? CTIX is a publicly traded company, albeit on the joker OTCBB (just look at yesterday's activity) . . . CTIX shareholders deserve a BOD . . . now! IMHO